NewGenIvf Group Ltd has announced a reverse stock split of its shares, consolidating its Class A ordinary shares at a ratio of one for every four shares. This decision, approved by the Board of Directors on September 16, 2026, aims to improve the company's stock price and attract more investors. The reverse stock split will take effect on October 12, 2026, at 12:01 a.m. ET, with shares trading on the Nasdaq Capital Market under the symbol NIVF.
The company, which operates in the services-misc health and allied services sector, is taking this step as part of its strategy to enhance its market position. By reducing the total number of outstanding shares from approximately 35.7 million to about 8.9 million, the company hopes to create a more favorable trading environment for its stock.
According to the filing, "The Reverse Stock Split will be effective at 12:01 a.m. (ET) on October 12, 2026." Following the split, all options, warrants, and other convertible securities will be adjusted accordingly. Importantly, no fractional shares will be issued; instead, shareholders entitled to fractional shares will receive one full share.
This move may impact various stakeholders, including existing shareholders, potential investors, and analysts monitoring the company’s performance. The decision to execute the reverse stock split without requiring shareholder approval reflects the company’s confidence in its strategy and the anticipated benefits of the consolidation.
Looking ahead, the company has not indicated any further actions or filings related to this decision. The next scheduled filing is set for October 21, 2026, which may provide additional insights into the company’s performance post-split.